MedPath
NMPA Approval

Urofollitropin for Injection

国药准字HJ20080050

January 26, 2025

H20080050

Drug Information

注射用尿促卵泡素

注射剂

75IU

化学药品

January 26, 2025

January 25, 2030

Company Information

Applicant Company

Lugano, Switzerland

Manufacturing Company

Via Serta 12, 6814 Lamone, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用尿促卵泡素 - NMPA 批准文号 | MedPath